SPX -0.58% VIX 4.38%
WAR OF WILL WINS 144TH PREAKNESS IN RACE THAT INCLUDED RIDERLESS HORSE
MICHIGAN GOP CONGRESSMAN SEEN AS FIRST OF PARTY TO SAY TRUMP ACTS IMPEACHABLE
AOC STANDS WITH BUFFETT: CEO NET WORTH SHOULD TAKE A HIT IF BAILOUT GIVEN
JOE BIDEN PITCHES HIMSELF AS A UNITER EVEN AS HE TEARS INTO TRUMP
HERE'S THE STOCK PLAY BOOSTED BY 'GAME OF THRONES' BANDWIDTH HOGS
THE TARIFF TIFF AND A FED RETHINK ARE JUST TWO AREAS OF STOCK-MARKET ANGST
ECONOMIC PREVIEW: CONSUMER SPENDING SLOWS, INVESTMENT HURT BY CHINA TRADE WAR
STRATEGIST: A NUMBER OF INDICATORS SUGGEST THE STOCK MARKET COULD EXTEND GAINS
AUSTRALIAS RULING CONSERVATIVE COALITION APPEARS HEADED TO A SURPRISE WIN
U.S. STOCKS END LOWER FOR DAY AND WEEK ON U.S.-CHINA TRADE UNCERTAINTY
Mon, May 20 4:39am



Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Progenics Pharmaceuticals Inc [PGNX]
$4.65 0.19 (3.93%)

PGNX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 410 Million
PGNX Description

Progenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA (to treat malignant and recurrent pheochromocytoma and paraganglioma); 1404 and PyL (imaging agents for prostate cancer); 1404 Index and PyL (analytical tools for analysis and indexing of images for prostate cancer); 1095 (treatment of metastatic prostate cancer); PSMA ADC (treatment of metastatic castration-resistant prostate cancer); and EXINI boneBSI (an analytical Bone Scan Index tool from bone scintigraphy images, currently sold in Europe and Japan). Its partnered products are RELISTOR (sold in the U.S., EU, Australia, and Canada) to treat opioid-induced constipation, and the PRO 140 HIV treatment.


Visit Website

PGNX Earnings

EPS -0.22 P/E Ratio 0.00
Previous Earnings Thu, Mar 14, 2019
Latest Earnings Thu, May 9, 2019 (11 days ago)

PGNX Dividend

Yield --
Ex-Date --
Pay Date --
History --

PGNX Charts

$3.64
52 Week Range
$9.18
Dec 24, 2018
Aug 3, 2018

4.65 0.41 0.00 0.00 PGNX NASDAQ -3.93 9.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PGNX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PGNX&exchange=NASDAQ&chart=1

Symbol Price % YTD
PGNX $4.65 -3.93% 9.41%


Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy